Disentangling ERBB Signaling in Breast Cancer Subtypes—A Model-Based Analysis

SIMPLE SUMMARY: Breast cancer subtypes are characterized by the expression and activity of estrogen-, progesterone- and HER2-receptors and differ by the treatment as well as patient prognosis. Tumors of the HER2-subtype overexpress this receptor and are successfully targeted with anti-HER2 therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemmer, Svenja, Berdiel-Acer, Mireia, Reinz, Eileen, Sonntag, Johanna, Tarade, Nooraldeen, Bernhardt, Stephan, Fehling-Kaschek, Mirjam, Hasmann, Max, Korf, Ulrike, Wiemann, Stefan, Timmer, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139462/
https://www.ncbi.nlm.nih.gov/pubmed/35625984
http://dx.doi.org/10.3390/cancers14102379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139462/
https://www.ncbi.nlm.nih.gov/pubmed/35625984
http://dx.doi.org/10.3390/cancers14102379

Ejemplares similares